A PYMNTS Company

US: Johnson & Johnson seeks $5.5B in damages 10 years after failed buyout

By  |  November 20, 2014

The world’s number-one healthcare product seller, Johnson & Johnson, is reportedly seeking damages 10 years after its failed buyout of Guidant Corp.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reports say the company has taken legal action against Boston Scientific, which ultimately won the bidding to acquire Guidant in 2004, on claims Boston Scientific broke a contract with Johnson & Johnson. J&J is now seeking up to $5.5 billion in damages.

    J&J had agreed to acquire Guidant for $21.5 billion, but an unsolicited bid from Boston Scientific lead Guidant to accept its ultimate offer of $27.5 billion. Guidant paid J&J a $705 million termination fee, reports say.

    Now, J&J argues that Boston Scientific unfairly interfered with its initial agreement with Guidant, and claims Guidant disclosed confidential business information to Boston Scientific.

    The case is set to run through November 25 then pick up against on December 15, according to reports.

    Full content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.